Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 7
2004 3
2005 10
2006 10
2007 5
2008 7
2009 2
2010 2
2011 3
2012 5
2013 2
2014 5
2015 4
2016 4
2017 6
2018 9
2019 11
2020 11
2021 13
2022 16
2023 5
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

130 results

Results by year

Filters applied: . Clear all
Page 1
Preface.
Söderbom G, Esterline R, Oscarsson J, Mattson MP. Söderbom G, et al. Among authors: oscarsson j. Int Rev Neurobiol. 2020;155:xiii-xviii. doi: 10.1016/S0074-7742(20)30134-3. Int Rev Neurobiol. 2020. PMID: 32854861 No abstract available.
Preface.
Söderbom G, Esterline R, Oscarsson J, Mattson MP. Söderbom G, et al. Among authors: oscarsson j. Int Rev Neurobiol. 2020;154:xv-xx. doi: 10.1016/S0074-7742(20)30115-X. Int Rev Neurobiol. 2020. PMID: 32739016 No abstract available.
Effects of SGLT2 inhibitor dapagliflozin in patients with type 2 diabetes on skeletal muscle cellular metabolism.
Op den Kamp YJM, Gemmink A, de Ligt M, Dautzenberg B, Kornips E, Jorgensen JA, Schaart G, Esterline R, Pava DA, Hoeks J, Schrauwen-Hinderling VB, Kersten S, Havekes B, Koves TR, Muoio DM, Hesselink MKC, Oscarsson J, Phielix E, Schrauwen P. Op den Kamp YJM, et al. Among authors: oscarsson j. Mol Metab. 2022 Dec;66:101620. doi: 10.1016/j.molmet.2022.101620. Epub 2022 Oct 21. Mol Metab. 2022. PMID: 36280113 Free PMC article. Clinical Trial.
Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on substrate metabolism in prediabetic insulin resistant individuals: A randomized, double-blind crossover trial.
Veelen A, Andriessen C, Op den Kamp Y, Erazo-Tapia E, de Ligt M, Mevenkamp J, Jörgensen JA, Moonen-Kornips E, Schaart G, Esterline R, Havekes B, Oscarsson J, Schrauwen-Hinderling VB, Phielix E, Schrauwen P. Veelen A, et al. Among authors: oscarsson j. Metabolism. 2023 Mar;140:155396. doi: 10.1016/j.metabol.2022.155396. Epub 2022 Dec 30. Metabolism. 2023. PMID: 36592688 Free article. Clinical Trial.
130 results